BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23189380)

  • 1. Methylphenidate: abuse and addiction.
    Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methylphenidate induced ST elevation acute myocardial infarction].
    Ruwald MH; Ruwald AC; Tønder N
    Ugeskr Laeger; 2012 Mar; 174(10):647-8. PubMed ID: 22395014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate-induced erections in a prepubertal child.
    Kelly BD; Lundon DJ; McGuinness D; Brady CM
    J Pediatr Urol; 2013 Feb; 9(1):e1-2. PubMed ID: 22552161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
    Gadow KD; Sverd J
    J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
    [No Abstract]   [Full Text] [Related]  

  • 16. First trimester in utero exposure to methylphenidate.
    Dideriksen D; Pottegård A; Hallas J; Aagaard L; Damkier P
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):73-6. PubMed ID: 23136875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R; Banaschewski T; Becker K
    Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 19. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 20. Abuse and toxicity of methylphenidate.
    Klein-Schwartz W
    Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.